|
Alan G. Harris, MD, PhD, FACP is Chairman of the Medical Advisory Board of Prolong Pharmaceuticals. He has 20 years of experience working in clinical drug development in the pharmaceutical industry and is currently the Chief Medical Officer of Manhattan Pharmaceuticals Inc. after serving as Corporate Head of the Worldwide Medical Endocrine Care group at Pfizer Inc, New York. Before that he served as Vice President Global Healthcare Research & Outcomes and Senior Director of Medical & Scientific Affairs at Schering-Plough Corporation, Kenilworth, New Jersey, where he was involved in the joint venture with Merck in the clinical development of the novel cholesterol medication, ezetimibe (Zetia ). Other responsibilities at Schering-Plough included research in products for the treatment of allergic and respiratory disorders, cardiovascular and metabolic diseases and hepatitis (Peg-Intron). During his tenure at Sandoz (Novartis) Pharmaceuticals in Basel, Switzerland, Dr. Harris developed the first clinically useful, long-acting somatostatin analog, octreotide (Sandostatin ®), for the treatment of gastrointestinal endocrine tumors and acromegaly.
Dr. Harris received his medical degree cum laude from the Louis Pasteur Faculty of Medicine, University of Strasbourg, France and his Ph.D. in Endocrinology from Erasmus University, Rotterdam, The Netherlands.Dr. Harris is currently Adjunct Professor of Medicine at NYU Medical School and Visiting Professor of Medicine in the Department of Endocrinology at Liège University Medical School, Belgium. Dr. Harris was Associate Professor of Medicine of UCLA School of Medicine, Director of the Division of Clinical Pharmacology in the Department of Medicine and Medical Director of the Department of Technology Development and Transfer and Clinical Trials at Cedars-Sinai Medical Center/UCLA School of Medicine, Los Angeles. Dr. Harris is a Fellow of the American College of Physicians, the Royal College of Physicians (UK), the American College of Clinical Pharmacology, the American College of Nutrition and the Royal Society of Medicine. Dr. Harris has authored over 100 peer reviewed scientific papers in the fields of endocrinology, diabetes mellitus, hepatogastroenterology, oncology, cardiology, allergy, immunology and respiratory medicine. | 